Papers: 10.1038/s41598-021-93107-w
https://doi.org/10.1038/s41598-021-93107-w
A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer
Cited by: 6
Author(s): Sander Palit, Jeroen van Dorp, Daniël J. Vis, Cor Lieftink, Simon Linder, Roderick L. Beijersbergen, Andries M. Bergman, Wilbert Zwart, Michiel S. van der Heijden
Published: about 4 years ago
Software Mentions 1
bioconductor: DESeq2
Differential gene expression analysis based on the negative binomial distributionPapers that mentioned: 9,583
Very Likely Science (100)